These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: Forskolin binding sites and G-protein immunoreactivity in rat hearts during aging. Author: Shu Y, Scarpace PJ. Journal: J Cardiovasc Pharmacol; 1994 Feb; 23(2):188-93. PubMed ID: 7511746. Abstract: Although the number of beta-adrenoceptors is unchanged with age in rat heart, both beta-adrenoceptor and postreceptor activation of adenylyl cyclase decreases with age. Pharmacologic data suggest that it is the amount of adenylyl cyclase enzyme units that limit activation of adenylyl cyclase with senescence, but direct quantitation of either G protein or adenylyl cyclase in rat heart with age is lacking. To quantitate the amount of adenylyl cyclase and G proteins with age directly, we assessed forskolin-stimulated adenylyl cyclase activity, the number of [3H] forskolin binding sites, and stimulatory G protein (Gs alpha) and inhibitory G protein (Gi alpha) immunoreactivity in the ventricles from 6- and 24-month-old F-344 rats. The amount of Gs alpha and Gi alpha was unchanged with age in both crude membranes and partially purified membranes from ventricles. In contrast, there was a 32% decrease in the ability of forskolin to stimulate adenylyl cyclase maximally and a 41% decrease in the number of forskolin binding sites with age. Sensitivity for forskolin activation was unchanged with age, but there was a slight increase in affinity for [3H]forskolin binding. The decrease in the amount of adenylyl cyclase with age correlates with the diminished capacity to activate adenylyl cyclase with age and may account for the reduced beta-adrenergic signal transduction observed in senescent rat heart.[Abstract] [Full Text] [Related] [New Search]